-
Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL
HOVON CLL Working Group, 28 Sept 2023, In: Blood. 142, 13, p. 1131-1142 12 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Immunogenicity of the 13-Valent Pneumococcal Conjugated Vaccine Followed by the 23-Valent Polysaccharide Vaccine in Chronic Lymphocytic Leukemia
Haggenburg, S., Garcia Garrido, H. M., Kant, I. M. J., van der Straaten, H. M., de Boer, F., Kersting, S., Issa, D., te Raa, D., Visser, H. P. J., Kater, A. P., Goorhuis, A. & de Heer, K., 1 Jul 2023, In: Vaccines. 11, 7, 1201.Research output: Contribution to journal › Article › Academic › peer-review
-
Validation of the Visual/Verbal Analogue Scale of Food Ingesta (Ingesta-VVAS) in Oncology Patients Undergoing Chemotherapy
Wijnhoven, H. A. H., van der Velden, L., Broek, C., Broekhuizen, M., Bruynzeel, P., van Breen, A., van Oostendorp, N. & de Heer, K., 1 Sept 2022, In: NUTRIENTS. 14, 17, p. 1-11 11 p., 3515.Research output: Contribution to journal › Article › Academic › peer-review
- All publications